Navigation Links
Generex Touts Pipeline Potential of Antigen Express Subsidiary
Date:2/7/2013

y (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One focuses on modification of peptides with Ii-Key to increase potency while a second relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual r
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
10. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
11. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015  The onset of puberty can make young athletes ... and thus more inclined toward a variety of injuries. ... body,s center of gravity is altered. It,s a period of ... quickly than the rest of the body and, in some ... year. And while these sudden changes are a natural part ...
(Date:3/6/2015)...   Prime Therapeutics LLC (Prime), a non-profit ... today released the following statement responding to the U.S. ... biosimilar to enter the U.S. market. ... Sandoz,s Zarxio® to treat neutropenia, a condition affecting about ... in our country,s journey to curb the escalating costs ...
(Date:3/6/2015)... LAKE FOREST, Ill. , March 6, 2015   ... and the U.S. Food and Drug Administration (FDA) on today,s ... United States . This is a watershed moment for ... medicines. As a leading global provider of biosimilars, Hospira has ... and we are a proud participant in these early stages ...
Breaking Medicine Technology:Puberty can result in variety of athletic injuries 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 3Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3
(Date:3/6/2015)... March 06, 2015 As the Muscular ... services programs, the organization has hired two new Scientific ... They will report to Grace Pavlath, Ph.D, who ... and Scientific Program Director, and together will lead MDA ... treatments and cures for various types of neuromuscular and ...
(Date:3/6/2015)... San Rafael, CA (PRWEB) March 06, 2015 ... the addition of three Maryland camps – two non-contact ... camps will be run by Perfect Performance Training, located ... camps will focus on developing position specific skills, speed ... will be hosted at Salisbury University with Marvin Graves, ...
(Date:3/6/2015)... Johnson & Johnson and Ethicon were hit ... 2015 in Superior Court in the State of California ... of 12 awarded Mrs. Perry $700,000 in actual damages ... Ethicon TVT Abbrevo plastic sling for stress urinary incontinence. ... awarded $5 million in punitive damages. , According to ...
(Date:3/6/2015)... March 06, 2015 Jvion, the ... release of a Clostridium Difficile (C Diff) predictive ... C Diff use case is the latest in ... hospital acquired infections, chronic conditions, and individual illnesses. ... C Diff solution flags at risk individuals to ...
(Date:3/6/2015)... In a new study conducted at a Warsaw hospital, ... pain was their first mesothelioma symptom. Surviving Mesothelioma has just ... to read it now. , Doctors at the Central ... mesothelioma patients between 2006 and 2012 and found ... that first prompted them to see a doctor. For some, ...
Breaking Medicine News(10 mins):Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2
... outbreak of Typhus fever has gripped people in Himachal ... women and children, in Deol area of Baijnath sub-division ... mysterious fever. ,Epidemiologists are suspecting the symptoms to ... typhus', caused by rickettsia, which is spread through bites ...
... study, accepting food cravings and keeping them in check ... ,The first six-month phase of the study provides ... craved, and their role in weight control. ... corresponding author Susan Roberts, PhD, director of the USDA ...
... New Guinea, Maura Elaripe Mea knows the harsh realities of living ... has seen AIDS patients left untreated because doctors feared it would ... not seek help simply because they cannot afford a bus ticket ... eight years ago, the former nurse said the treatment of AIDS ...
... years ago, he lost both hands in a letter bomb explosion. ... motorbike, undeterred by a double hand transplant. ,His ... ,Theo Kelz, a medical wonder with an iron will, was ... from 1993 until his arrest in 1997 with a wave of ...
... gain approval from the Food and Drug Administration (FDA), but ... Wilson Guthrie, a 61-year-old man from Kansas, suffering from end-stage ... with that experimental heart-assist device that keeps his heart pumping. ... cardiothoracic ICU has had, and that a lot of technology ...
... experiencing memory loss are more likely than women without cognitive ... to a study. ,For the study, ... signs of memory problems underwent cognitive tests over 15 years. ... ,The study found the nearly 25 percent of ...
Cached Medicine News:Health News:Weight Management Achieved by Controlling and Not Suppressing Food Cravings 2Health News:Thousands Gather in Sydney for HIV Conference 2Health News:Around the World in 86 Days ... on Motorbike With Double-hand Transplant 2Health News:Around the World in 86 Days ... on Motorbike With Double-hand Transplant 3Health News:US Patient Implanted With HeartMate II, Leaves ICU 2Health News:Older Women With Memory Problems at Increased Risk for Restless Nights 2
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
For the quantitative determination of aspartate aminotransferase in serum. Optimized IFCC procedure without P-5'-P. 500 IU/L at 37C linearity....
The Definitive automated slide stainer is an industry standard. The Definitive allows automated slide staining in a compact, self-contained and easy-to use package....
... an "assembly-line worker" for routine staining protocols ... Programmable continuous slide stainer for routine stains. ... in short time. Its large number of ... working principle provides a high throughput. A ...
Medicine Products: